Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 4
1994 5
1996 3
1997 4
1998 2
1999 5
2000 11
2001 7
2002 3
2003 5
2004 3
2005 4
2006 9
2007 5
2008 7
2009 10
2010 8
2011 8
2012 9
2013 13
2014 7
2015 4
2016 5
2017 6
2018 1
2019 7
2020 7
2021 6
2022 2
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

163 results

Results by year

Filters applied: . Clear all
Page 1
Plasma protein biomarkers for early prediction of lung cancer.
Davies MPA, Sato T, Ashoor H, Hou L, Liloglou T, Yang R, Field JK. Davies MPA, et al. Among authors: liloglou t. EBioMedicine. 2023 Jul;93:104686. doi: 10.1016/j.ebiom.2023.104686. Epub 2023 Jun 26. EBioMedicine. 2023. PMID: 37379654 Free PMC article.
Epigenetic biomarkers in lung cancer.
Liloglou T, Bediaga NG, Brown BR, Field JK, Davies MP. Liloglou T, et al. Cancer Lett. 2014 Jan 28;342(2):200-12. doi: 10.1016/j.canlet.2012.04.018. Epub 2012 Apr 27. Cancer Lett. 2014. PMID: 22546286 Review.
Lung cancer epigenetics: emerging biomarkers.
Balgkouranidou I, Liloglou T, Lianidou ES. Balgkouranidou I, et al. Among authors: liloglou t. Biomark Med. 2013 Feb;7(1):49-58. doi: 10.2217/bmm.12.111. Biomark Med. 2013. PMID: 23387484 Free article. Review.
Non-coding RNA-directed therapeutics in lung cancer: Delivery technologies and clinical applications.
Abdellatif AAH, Scagnetti G, Younis MA, Bouazzaoui A, Tawfeek HM, Aldosari BN, Almurshedi AS, Alsharidah M, Rugaie OA, Davies MPA, Liloglou T, Ross K, Saleem I. Abdellatif AAH, et al. Among authors: liloglou t. Colloids Surf B Biointerfaces. 2023 Sep;229:113466. doi: 10.1016/j.colsurfb.2023.113466. Epub 2023 Jul 18. Colloids Surf B Biointerfaces. 2023. PMID: 37515959 Review.
Strategies for validation and testing of DNA methylation biomarkers.
Noehammer C, Pulverer W, Hassler MR, Hofner M, Wielscher M, Vierlinger K, Liloglou T, McCarthy D, Jensen TJ, Nygren A, Gohlke H, Trooskens G, Braspenning M, Van Criekinge W, Egger G, Weinhaeusel A. Noehammer C, et al. Among authors: liloglou t. Epigenomics. 2014;6(6):603-22. doi: 10.2217/epi.14.43. Epigenomics. 2014. PMID: 25531255 Review.
Lung cancer risk prediction: a tool for early detection.
Cassidy A, Duffy SW, Myles JP, Liloglou T, Field JK. Cassidy A, et al. Among authors: liloglou t. Int J Cancer. 2007 Jan 1;120(1):1-6. doi: 10.1002/ijc.22331. Int J Cancer. 2007. PMID: 17058200 Free article. Review.
Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties.
Barrera LN, Evans A, Lane B, Brumskill S, Oldfield FE, Campbell F, Andrews T, Lu Z, Perez-Mancera PA, Liloglou T, Ashworth M, Jalali M, Dawson R, Nunes Q, Phillips PA, Timms JF, Halloran C, Greenhalf W, Neoptolemos JP, Costello E. Barrera LN, et al. Among authors: liloglou t. Cancer Res. 2020 Jul 1;80(13):2861-2873. doi: 10.1158/0008-5472.CAN-19-3534. Epub 2020 May 11. Cancer Res. 2020. PMID: 32393661
163 results